Santa Cruz Biotechnology

WT1 (F-6) AC | Santa Cruz Biotechnology

mouse monoclonal IgG1; WT1 Antibody (F-6) is an IgG1 mouse monoclonal WT1 antibody that detects the WT1 protein of mouse, rat and human origin by WB, IP and IF. WT1 Antibody (F-6) is available as both the non-conjugated anti-WT1 antibody form, as well as multiple conjugated forms of anti-WT1 antibody, including agarose and multiple Alexa Fluor® conjugates. Wilms' tumor (WT) is an embryonal malignancy of the kidney that affects 1 in 10,000 infants and, like retinoblastoma, is observed in both sporadic and inherited forms. The Wilms' tumor locus has been mapped at chromosome 11p13 as a tumor suppressor gene which encodes a DNA binding protein with four zinc fingers and a glutamine-proline rich amino-terminus. The Wilms' tumor protein (WT1) binds the DNA sequence GCGGGGGCG, a recognition element common to the early growth response (Egr) family of Zn2+ finger transcriptional activators. However, in contrast to Egr transcription factors, WT1 behaves as a transcriptional repressor in transient transfection assays with synthetic promotor constructs.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.